Scientists find finerenone may stimulate ovarian follicles and help restore fertility in women with POI, offering a potential ...
Morning Overview on MSN
New research shows alcohol disrupts key brain cell signaling pathways
A wave of recent neuroscience research has identified specific molecular and cellular mechanisms through which alcohol disrupts signaling between brain cells, offering a sharper picture of how ...
Celcuity recently reported in the Journal of Clinical Oncology that its Phase 3 VIKTORIA-1 trial in PIK3CA wild-type HR-positive, HER2-negative advanced breast cancer showed gedatolisib-based regimens ...
News Medical on MSN
EVA1A regulates fatty acid transporter CD36 in fatty liver disease
Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD) is characterized by excessive accumulation of lipids in hepatocytes and is closely associated with the rapid rise in insulin resistance, ...
A new synthesis finds that common epilepsies are driven by thousands of tiny-effect genetic variants, most still ...
Researchers identified finerenone as a potential treatment for POI. Preclinical findings show the drug stimulates follicle ...
As previously presented, gedatolisib + palbociclib + fulvestrant (“gedatolisib triplet”) and gedatolisib + fulvestrant (“gedatolisib doublet”) ...
Equity-Insider.com News Commentary -- Big money is moving back into biotech. Institutional investors have been writing some of the largest checks in years, with major financing rounds already closing ...
Reagenics Research produces protein inside potatoes via plant cell culture, and studies show its low methionine content can help build muscle and slow ageing. Could the spud be the key to longevity?
Premature ovarian insufficiency (POI) affects 1–3% of women and has limited treatment options. Researchers report that ovarian fibrosis may restrict follicle development and that the antifibrotic drug ...
The Genomic Press Interview in Brain Medicine titled "Gabriella Gobbi: Embracing psychiatry from bench to bedside," is freely available via Open Access, starting on 17 March 2026 in Brain Medicine at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results